第二代非肽类肾素抑制剂的研究现状及应用前景

下载PDF

导出

摘要作为RAS系统药物中的新成员,肾素抑制剂在临床的应用还刚刚起步,我们期待更多的临床试验对其进一步的评价。

作者刘惠霞

机构地区广东省人民医院心血管内科

出处《中国处方药》 2009年第12期29-31,共3页 Journal of China Prescription Drug

关键词肾素抑制剂非肽类第二代临床试验系统药物 RAS

参考文献10

1Ferro A,,Pitt B.Renin imhibitors:an important advance in hypertension Treatment[].International Journal of Clinical Practice.2006
2Andersen k,Weinberger MH,Egan B.et al.Comparative efficacy and safety of Aliskiren an oral direct rennin inhibitor,and ramipril in hypertension:a6-month randomized,double blind trial[].J HypertensJournal of Hypertension.2008
3Gradman AH,Schmieder RE,Lins RL,et al.Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients[].Circulation.2005
4Gradman AH,Kad R.Renin inhibition in hypertension[].Journal of the American College of Cardiology.2008
5Kappert K,Unger T,Kintscher U.Aliskiren hemifumarate[].Deutsche Medizinische Wochenschrift.2008
6Wood,JM,Maibaum,J,Rahuel,J.Structure-based design of aliskiren, a novel orally effective renin inhibitor[].Biochemical and Biophysical Research Communications.2003
7Novartis Pharmaceuticals Corporation.Tekturna(aliskiren). NDA21-985 . 2007
8Rashid H.Direct renin inhibition: an evaluation of the safety and tolerability of aliskiren[].Current Medical Research and Opinion.2008
9WALDMEIER FJ,GLAENZEL U,WIRZ B,et al.Absorption, distribution,metabolism and elimination of the direct renin inhib- itor aliskiren in healthy volunteers[].Drug Metabolism and Disposition.2007
10Laustsen G.Aliskiren(Tekturna)a new weapon to battlethe silent killer[].Nurse Practitioner.2007

中国处方药

2009年第12期

内容加载中请稍等...